한글목차

세계 정량 흡입기 시장 규모는 4.9%의 CAGR로 확대되어 2025년 310억 3,000만 달러에서 2032년 433억 5,000만 달러로 성장할 것으로 예상됩니다. MDI는 천식이나 만성폐쇄성폐질환(COPD)과 같은 증상에 대한 정확한 약물 투여를 보장하는 호흡기 약물 전달에 있어 매우 중요한 역할을 하고 있습니다.

정량 흡입기는 에어로졸화 된 약물을 효과적으로 전달하기 위해 설계된 소형 핸드헬드 기기입니다. 휴대성, 사용 편의성, 높은 정확성으로 인해 호흡기질환 관리에 필수적인 도구가 되었습니다. 전 세계적으로 호흡기질환의 증가와 흡입기 기술의 발전으로 인해 MDI에 대한 수요가 크게 증가하고 있습니다.

흡입기 설계 및 제형 혁신이 주요 성장 요인으로 작용하고 있습니다. 제약회사와 연구기관의 협력은 디지털 기술과 센서가 통합된 지능형 흡입기의 길을 열어 환자의 순응도를 개선하고 개별화된 치료를 가능하게 했습니다. 천식, COPD 및 기타 호흡기질환의 증가로 인해 효과적인 흡입 요법에 대한 수요가 증가하고 있으며, MDI의 사용자 친화적인 디자인과 디지털 솔루션은 환자의 참여도를 높이고 처방된 치료에 대한 순응도를 향상시키고 있습니다.

커넥티드 디바이스와 디지털 헬스 플랫폼의 등장은 세계 정량 흡입기 시장에 큰 비즈니스 기회를 제공하고 있습니다. 센서가 내장된 스마트 흡입기는 약물 사용에 대한 실시간 데이터를 제공하여 의료 서비스 제공자가 치료 전략을 조정하고 환자 결과를 개선할 수 있도록 도와줍니다. 이러한 장치는 또한 모바일 앱을 통해 제공되는 피드백, 알림 및 교육 도구를 통해 환자에게 힘을 실어줍니다.

세계의 정량 흡입기 시장에 대해 조사했으며, 시장 개요와 함께 유형별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 가격 분석, 2019-2023년

제4장 세계의 정량 흡입기 시장 전망, 2019-2032년

• 세계의 정량 흡입기 시장 전망, 유형별, 금액(10억 달러), 수량(100만 대), 2019-2032년
• 세계의 정량 흡입기 시장 전망, 최종사용자별, 금액(10억 달러), 수량(100만 대), 2019-2032년
• 세계의 정량 흡입기 시장 전망, 지역별, 금액(10억 달러), 수량(100만 대), 2019-2032년

제5장 북미의 정량 흡입기 시장 전망, 2019-2032년

제6장 유럽의 정량 흡입기 시장 전망, 2019-2032년

제7장 아시아태평양의 정량 흡입기 시장 전망, 2019-2032년

제8장 라틴아메리카의 정량 흡입기 시장 전망, 2019-2032년

제9장 중동 및 아프리카의 정량 흡입기 시장 전망, 2019-2032년

제10장 경쟁 구도

• 유형과 최종사용자 히트맵
• 기업 시장 점유율 분석, 2024년
• 경쟁 대시보드
• 기업 개요
  • Cipla Inc.
  • Presspart Manufacturing Ltd.
  • Midascare Pharmaceuticals Pvt. Ltd.
  • Beximco Pharma Ltd.
  • GlaxoSmithKline Pharmaceuticals Ltd.
  • 3M Pharmaceuticals Pty Ltd.
  • Biocare Manufacturing Sdn Bhd.
  • Anomatic Innovation & Design Center & Manufacturing
  • Aristo Pharma Ltd.

제11장 부록

영문목차

The global metered dose inhalers market is on track for notable growth, with a projected compound annual growth rate (CAGR) of 4.9%. It is anticipated to grow from USD 31.03 billion in 2025 to USD 43.35 billion by 2032. MDIs play a pivotal role in respiratory drug delivery, ensuring precise and controlled administration of medication for conditions like asthma and chronic obstructive pulmonary disease (COPD).

Metered dose inhalers are compact, handheld devices designed to effectively deliver aerosolized medication. Their portability, ease of use, and precision make them essential tools in managing respiratory disorders. Increasing cases of respiratory diseases worldwide, along with advancements in inhaler technology, have significantly driven the demand for MDIs.

Key Market Drivers

• 1.Technological Advancements: Innovation in inhaler design and formulation has been a major growth factor. Collaborations between pharmaceutical firms and research institutions have paved the way for intelligent inhalers integrated with digital technology and sensors, improving patient adherence and enabling personalized treatments.
• 2.Rising Respiratory Disease Burden: Growing incidences of asthma, COPD, and other respiratory disorders are driving the demand for effective inhalation therapies.
• 3.Patient-Centric Features: The inclusion of user-friendly designs and digital solutions in MDIs has enhanced patient engagement and adherence to prescribed treatments.

Business Opportunities

The rise of connected devices and digital health platforms presents significant opportunities in the global metered dose inhalers market. Smart inhalers embedded with sensors provide real-time data on medication usage, enabling healthcare providers to tailor treatment strategies and enhance patient outcomes. These devices also empower patients through feedback, reminders, and educational tools available via mobile apps.

Market Restraints

• 1.Environmental Concerns: Conventional MDIs depend on hydrofluoroalkane (HFA) propellants, which have high global warming potential. Regulatory efforts are urging manufacturers to transition to more eco-friendly alternatives.
• 2.Regulatory Challenges: Complex and evolving regulatory requirements for new inhaler technologies pose significant hurdles for manufacturers, necessitating rigorous validation and compliance efforts.

Regional Analysis

• 1.Asia Pacific: The region is expected to lead the market, driven by a large population base with a high prevalence of respiratory conditions. Countries like China and India are seeing increased adoption of advanced respiratory therapies due to better healthcare infrastructure and economic growth.
• 2.Latin America: The fastest-growing region, Latin America's market expansion is propelled by rising awareness of respiratory health, improved healthcare facilities, and access to advanced inhaler technologies.
• 3.North America and Europe: These regions remain major markets due to high healthcare spending and advanced infrastructure, although the Asia Pacific region is emerging as a critical growth area for industry players.

Competitive Analysis

The metered dose inhalers market is highly competitive, with leading players focusing on innovation, partnerships, and global expansion to strengthen their market presence. Key companies include:

• Cipla Inc.
• Presspart Manufacturing Ltd.
• Midascare Pharmaceuticals Pvt. Ltd.
• Beximco Pharma Ltd.
• GlaxoSmithKline Pharmaceuticals Ltd.
• 3M Pharmaceuticals Pty Ltd.
• Biocare Manufacturing Sdn Bhd.
• Anomatic Innovation & Design Center & Manufacturing
• Aristo Pharma Ltd.

Metered Dose Inhalers Market Segmentation

• By Type:
• Reliever Inhaler
• Long-acting Bronchodilator Inhaler
• By End Use:
• Homecare
• Hospitals
• Clinics
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Metered Dose Inhalers Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

• 3.1. Global Average Price Analysis, by Type, US$ Per Unit, 2019 - 2023
• 3.2. Prominent Factor Affecting Metered Dose Inhalers Prices
• 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Metered Dose Inhalers Market Outlook, 2019 - 2032

• 4.1. Global Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Reliever Inhaler
    • 4.1.1.2. Long-acting bronchodilators Inhaler
• 4.2. Global Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Homecare
    • 4.2.1.2. Hospitals
    • 4.2.1.3. Clinics
• 4.3. Global Metered Dose Inhalers Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. North America
    • 4.3.1.2. Europe
    • 4.3.1.3. Asia Pacific
    • 4.3.1.4. Latin America
    • 4.3.1.5. Middle East & Africa

5. North America Metered Dose Inhalers Market Outlook, 2019 - 2032

• 5.1. North America Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Reliever Inhaler
    • 5.1.1.2. Long-acting bronchodilators Inhaler
• 5.2. North America Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Homecare
    • 5.2.1.2. Hospitals
    • 5.2.1.3. Clinics
• 5.3. North America Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. U.S. Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.2. U.S. Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.3. Canada Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 5.3.1.4. Canada Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Metered Dose Inhalers Market Outlook, 2019 - 2032

• 6.1. Europe Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Reliever Inhaler
    • 6.1.1.2. Long-acting bronchodilators Inhaler
• 6.2. Europe Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Homecare
    • 6.2.1.2. Hospitals
    • 6.2.1.3. Clinics
• 6.3. Europe Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Germany Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.2. Germany Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.3. U.K. Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.4. U.K. Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.5. France Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.6. France Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.7. Italy Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.8. Italy Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.9. Turkey Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.10. Turkey Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.11. Russia Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.12. Russia Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.13. Rest of Europe Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 6.3.1.14. Rest of Europe Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Metered Dose Inhalers Market Outlook, 2019 - 2032

• 7.1. Asia Pacific Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Reliever Inhaler
    • 7.1.1.2. Long-acting bronchodilators Inhaler
• 7.2. Asia Pacific Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Homecare
    • 7.2.1.2. Hospitals
    • 7.2.1.3. Clinics
• 7.3. Asia Pacific Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. China Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.2. China Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.3. Japan Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.4. Japan Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.5. South Korea Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.6. South Korea Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.7. South Korea Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.8. India Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.9. India Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.10. Southeast Asia Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.11. Southeast Asia Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.12. Rest of Asia Pacific Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 7.3.1.13. Rest of Asia Pacific Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Metered Dose Inhalers Market Outlook, 2019 - 2032

• 8.1. Latin America Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Reliever Inhaler
    • 8.1.1.2. Long-acting bronchodilators Inhaler
• 8.2. Latin America Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Homecare
    • 8.2.1.2. Hospitals
    • 8.2.1.3. Clinics
• 8.3. Latin America Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Brazil Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.2. Brazil Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.3. Mexico Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.4. Mexico Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.5. Argentina Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.6. Argentina Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.7. Rest of Latin America Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 8.3.1.8. Rest of Latin America Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Metered Dose Inhalers Market Outlook, 2019 - 2032

• 9.1. Middle East & Africa Metered Dose Inhalers Market Outlook, by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Reliever Inhaler
    • 9.1.1.2. Long-acting bronchodilators Inhaler
• 9.2. Middle East & Africa Metered Dose Inhalers Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Homecare
    • 9.2.1.2. Hospitals
    • 9.2.1.3. Clinics
• 9.3. Middle East & Africa Metered Dose Inhalers Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. GCC Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.2. GCC Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.3. South Africa Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.4. South Africa Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.5. Egypt Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.6. Egypt Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.7. Nigeria Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.8. Nigeria Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.9. Rest of Middle East & Africa Metered Dose Inhalers Market by Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
    • 9.3.1.10. Rest of Middle East & Africa Metered Dose Inhalers Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2032
  • 9.3.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

• 10.1. Type vs End User Heatmap
• 10.2. Company Market Share Analysis, 2024
• 10.3. Competitive Dashboard
• 10.4. Company Profiles
  • 10.4.1. Cipla Inc.
    • 10.4.1.1. Company Overview
    • 10.4.1.2. Product Portfolio
    • 10.4.1.3. Financial Overview
    • 10.4.1.4. Business Strategies and Development
  • 10.4.2. Presspart Manufacturing Ltd.
    • 10.4.2.1. Company Overview
    • 10.4.2.2. Product Portfolio
    • 10.4.2.3. Financial Overview
    • 10.4.2.4. Business Strategies and Development
  • 10.4.3. Midascare Pharmaceuticals Pvt. Ltd.
    • 10.4.3.1. Company Overview
    • 10.4.3.2. Product Portfolio
    • 10.4.3.3. Financial Overview
    • 10.4.3.4. Business Strategies and Development
  • 10.4.4. Beximco Pharma Ltd.
    • 10.4.4.1. Company Overview
    • 10.4.4.2. Product Portfolio
    • 10.4.4.3. Financial Overview
    • 10.4.4.4. Business Strategies and Development
  • 10.4.5. GlaxoSmithKline Pharmaceuticals Ltd.
    • 10.4.5.1. Company Overview
    • 10.4.5.2. Product Portfolio
    • 10.4.5.3. Financial Overview
    • 10.4.5.4. Business Strategies and Development
  • 10.4.6. 3M Pharmaceuticals Pty Ltd.
    • 10.4.6.1. Company Overview
    • 10.4.6.2. Product Portfolio
    • 10.4.6.3. Financial Overview
    • 10.4.6.4. Business Strategies and Development
  • 10.4.7. Biocare Manufacturing Sdn Bhd.
    • 10.4.7.1. Company Overview
    • 10.4.7.2. Product Portfolio
    • 10.4.7.3. Financial Overview
    • 10.4.7.4. Business Strategies and Development
  • 10.4.8. Anomatic Innovation & Design Center & Manufacturing
    • 10.4.8.1. Company Overview
    • 10.4.8.2. Product Portfolio
    • 10.4.8.3. Financial Overview
    • 10.4.8.4. Business Strategies and Development
  • 10.4.9. Aristo Pharma Ltd.
    • 10.4.9.1. Company Overview
    • 10.4.9.2. Product Portfolio
    • 10.4.9.3. Financial Overview
    • 10.4.9.4. Business Strategies and Development

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations